🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recurrent miscarriage (RM) defined by \>=3 consecutive losses affects 1% of...
Status
Unknown
Location
Centre Hospitalier Annecy Genevois
Start Date
2017-12-04
Trial ID
NCT03165136
Treatments Being Tested
The purpose of this Phase I/II study is to determine the safety and effecti...
Status
Recruiting
Location
Medical University of South Carolina
Start Date
2022-03-03
Trial ID
NCT05036226
Treatments Being Tested
To investigate efficacy and safety of Hydroxychloroquin in improving pregna...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-01
Trial ID
NCT05237843
Treatments Being Tested
Undifferentiated connective tissue diseases (UCTD) are known to increase th...
Status
Unknown
Location
Renji Hospital
Start Date
2019-08-02
Trial ID
NCT03671174
Treatments Being Tested
Liver metastases are a leading cause of death among patients with metastati...
Status
Terminated
Location
Abramson Cancer Center
Start Date
2022-01-24
Trial ID
NCT04873895
Treatments Being Tested
The host response against the coronavirus 2 (SARS-CoV-2) appears to be medi...
Status
Suspended
Location
Hospital La Milagrosa, GenesisCare
Start Date
2020-04-21
Trial ID
NCT04394182
RATIONALE: Studying samples of blood, tumor tissue, and skin in the laborat...
Status
Completed
Location
Rutgers Cancer Institute of New Jersey
Start Date
2010-09
Trial ID
NCT00962845
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of the current t...
Status
Unknown
Location
The Second Xiangya Hospital, Central South University
Start Date
2018-12-01
Trial ID
NCT03791827
The purpose of this study is to evaluate the efficacy of ustekinumab as mea...
Status
Completed
Location
Multiple Locations
Start Date
2015-10-15
Trial ID
NCT02349061
Treatments Being Tested
This phase I trial studies the side effects and the best dose of Akt inhibi...
Status
Active Not Recruiting
Location
Rutgers Cancer Institute of New Jersey
Start Date
2011-11-23
Trial ID
NCT01480154
Treatments Being Tested